Nano Labs Ltd. Sponsored ADR NA
2.38
0.06
2.59%
as of 25 Sep
- Market cap
- $56.7M
- P/E
- —
Follow NA
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Dec '24 | Jun '25 | Dec '25 | Jun '26 | |
|---|---|---|---|---|---|
EV/Sales |
+7 more quarters Free account |
— | — | — | — |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.16 | 0.53 | 0.28 | 0.32 | |
Current Ratio |
1.75 | 1.81 | 2.09 | 1.20 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
28.58% | 44.02% | 16.95% | 27.19% | |
Debt/Equity |
0.76 | 1.05 | 0.26 | 0.52 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(3.13) | 0.24 | 0.15 | 0.00 | |
Intangible Assets out of Total Assets |
0.08 | 0.03 | 0.04 | 0.06 | |
Share Based Compensation of Revenue |
— | 0.00% | — | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(24.44) | (6.89) | (15.15) | (8.21) | |
Working Capital |
21.87 | 77.50 | 31.99 | 5.02 | |
Capital Expenditures |
(5.06) | 0.21 | 0.26 | 0.00 | |
Net Current Asset Value |
(2.28) | 52.96 | 7.44 | (21.17) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.14 | 0.16 | 1.50 | 0.18 | |
Average Payables |
5.16 | 2.81 | 2.66 | 1.82 | |
Average Inventory |
4.98 | 3.41 | 1.59 | 1.04 | |
Average Assets |
63.38 | 127.94 | 105.24 | 82.00 | |
Average Common Equity |
18.41 | 42.09 | 50.62 | 30.30 |
Columns are period end dates